926294-07-7 Usage
Uses
Used in Pharmaceutical Industry:
6-Bromo-4-methyl-pyridine-3-carbaldehyde is used as a building block for the synthesis of various pharmaceutical products. Its unique structure and reactivity contribute to the development of new drug candidates with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 6-Bromo-4-methyl-pyridine-3-carbaldehyde serves as a key intermediate in the synthesis of agrochemical products, such as pesticides and herbicides, due to its versatile reactivity and potential to create active compounds.
Used in Medicinal Chemistry Research:
6-Bromo-4-methyl-pyridine-3-carbaldehyde is utilized as a precursor in the synthesis of fine chemicals and as a key intermediate in the development of new drug candidates. Its unique properties make it an important compound for research in medicinal chemistry, contributing to the discovery of novel therapeutic agents.
Used in Drug Discovery:
6-Bromo-4-methyl-pyridine-3-carbaldehyde plays a significant role in drug discovery, as its versatile reactivity allows for the creation of various pharmacologically active compounds. Its potential application in the development of new drug candidates highlights its importance in advancing the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 926294-07-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,2,9 and 4 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 926294-07:
(8*9)+(7*2)+(6*6)+(5*2)+(4*9)+(3*4)+(2*0)+(1*7)=187
187 % 10 = 7
So 926294-07-7 is a valid CAS Registry Number.
926294-07-7Relevant academic research and scientific papers
CHEMOKINE RECEPTOR BINDING COMPOUNDS
-
Page/Page column 51, (2010/11/26)
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
